Vincent O'Neill, Chief Medical Officer at BioXcel Therapeutics, Inc. (BTAI), sold 45,800 shares at $48.43 ($2.3M) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market sale of $2.3M BTAI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.43 | 6,758 | $327K | 14.5% |
| 2 | $48.43 | 6,758 | $327K | 14.5% |
| 3 | $49.27 | 12,665 | $624K | 27.6% |
| 4 | $49.27 | 12,665 | $624K | 27.6% |
| 5 | $50.38 | 2,700 | $136K | 6.0% |
| 6 | $51.45 | 1,500 |
| $77K |
| 3.4% |
| 7 | $52.45 | 1,377 | $72K | 3.2% |
| 8 | $52.45 | 1,377 | $72K | 3.2% |
| Total | $49.35 avg | 45,800 | $2.3M | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $95 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $200 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $432 | — | Filing → |